Hepatitis Flashcards
Transmission HAV
Faecal to oral
Transmission HBV
Parenteral
Sexual
Perinatal
Transmission HCV
Parenteral
Sexual
Perinatal
Transmission HDV
Parenteral
Transmission HEV
Faecal-oral
Main risk population for HAV
Travellers to endemic areas
Sewage workers
Contacts of cases
Main risk populations for HBV
Immigrants from high prevalence areas PWID Multiple sexual partners Infants of HBsAg +ve mothers Health care workers
Main risk population for HCV
PWID
Recipients of unscreened blood products
Main risk populate HDV
PWID
Main risk population for HEV
Travellers to endemic areas
Sporadic
exposure to undercooked pig products
Chronic infection rate in HAV
None
Chronic infection rate in HBV
5-10%
Chronic infection rate in HCV
60-80%
Chronic infection rate in HDV
People infected with HBV
Chronic sequelae in HAV
None
Chronic sequelae in HBV
Chronic hepatitis
Cirrhosis
Hepatoma
Chronic sequelae in HCV
Chronic hepatitis
Cirrhosis
Hepatoma
Chronic sequelae in DV
Chronic hepatitis
Cirrhoses
Who is HEV VERY dangerous for?
Pregnant women
What is the prevention of HAV
Inactivated vaccine
What is the prevention of HBV
Recombinant vaccine
For which of the hepatitis are there no vaccine
HCV
HDV (need to immunise against HBV to protect)
HEV
Where is there a HDV vaccine present?
China
For which is there a vaccine
A and B
For which is there no vaccine?
C
Rx for HBV
Pegylated interferon Nucleoside analogues Liver Tx (for advanced cirrhosis)
Nucleoside analogues used in HBV
Lamivudine Adefovir Dipivoxil Telbivudine Entecavir
What is the main prevention of HBV
Vaccination
Who is recommended for HBV vaccination
Health care workers Travelling to endemic areas Renal dialysis PWID Close contacts with those who have acute/chronic HBV
Which hepatitis viruses can be transmitted from the faecal-oral route?
A and E
How can HAV and HEV be prevented?
Good hand hygiene Good sanitation Clean water Human normal immunoglobulin (HAV) Active immunisation (HAV)
How is HAV Dx in the laboratory
Detection of hepatitis A lgM antibody
in a serum sample.
Which hepatitis virus are spread by infected blood
B, C, D
How can HBV, HCV and HDV be prevented
Infection control precautions
Screening blood products
Safe sex
Vaccination for HBV
What is the purpose for testing serum for anti-abc IgM antibody?
Its presence indicates recent hepatitis
B infection. If a patient is tested late in the course of illness, HBsAg may have disappeared but the presence of IgM-anti HBc indicates recent infection.
Define chronic HB infection
HBsAg is persent in serum for at least 6 months
What percentage of adults will become chronically infected with HBV after acute infection
5-10%
What percentage of children with acute HBV will become chronically infected
40%
What percentage of infants with acute HBV infection will become chronically infected
90%
Who should be vaccinated against HBV?
Healthcare workers
Close contacts of those with acute or chronic HBV infection
Selected police and emergency services
PWID
Individuals who change sexual partners frequently
Inmates of custodial institutions
Some patients with chronic liver disease
What is the clinical important of infection with HCV
60-80% will show evidence of chronic liver disease and are at risk of progression to cirrhosis
What laboratory assessment would you make of someone with antibodies to HCV
Serum ALT
HCV RNA
What factors is essential for the transmission of HDV
Presence of HBsAg
What is the commonest mode of hepatitis D transmission
Injection drug use
Interpret:
History of recent jaundice in a 26 year old homosexual.
Hepatitis B surface antigen negative. Hepatitis B core antibody negative. Hepatitis A IgM positive.
Evidence for recent hepatitis A infection
No evidence for hepatitis B infection
Interpret:
Antenatal screen in a 30 year old woman.
Hepatitis B surface antigen positive. Hepatitis B e antigen positive.
Hepatitis B e antibody negative. Hepatitis B core IgM antibody negative. Hepatitis B core total antibody positive.
Results consistent with chronic hepatitis B infection. The presence of surface antigen indicates infectivity. The presence of e antigen indicates high infectivity.
The absence of IgM anti-core indicates the infection is not recent.
Arrangements should be made in advance so that the baby is protected against HBV
Interpret: History of past injecting drug use. Hepatitis A antibody negative Hepatitis B surface antigen negative. Hepatitis B core total antibody positive. Hepatitis B surface antibody positive. Hepatitis C antibody positive. Hepatitis C RNA positive.
No recent or past infection with HAV
Results consistent with past HBV with seroconversion to antibodies
Ongoing infection with HCV
Interpret:
Recent onset jaundice in a 65 year old diabetic man who has not been abroad recently.
Hepatitis A IgM negative.
Hepatitis B surface antigen negative. Hepatitis B core total antibody negative. Hepatitis C antibody negative.
Hepatitis E IgG antibody positive. Hepatitis E IgM antibody positive. Hepatitis E RNA positive
Recent HEV
No evidence for recent HAV detected
No evidence for infection with HBV
Interpret:
Going to live in Africa. Is immunisation needed?
Hepatitis A total antibody positive. Hepatitis B core total antibody negative.
Evidence for past infection with hepatitis A immunisation not indicated
No evidence for previous HBV infection
Immunisation is indicated
Interpret:
HBsAg negative
Anti-HBc negative
Anti-hBs negative
No infection
But not immunised
Therefore susceptible
Interpret:
HBsAg negative
anti-HBC positive
anti-HBs positive
Resolved past infection
Interpret:
HBsAg negative
Anti-HBC negative
Anti-HBs positive
Immunity due to vaccination
Interpret:
HBsAg positive
Anti-HBC positive
Anti-HBs negative
Active HBV infection
What does the present of Anti-HBC IgM indicated
May represent acute infection
What does the presence of Anti-HBC IgG indicate
May represent more chronic HBV infection
Interpret Vaccination result >100 Anti-HBs
Good response
Booster in 5 yrs
Interpret Vaccination result 10-100
Response but poor response
Booster now and in 5yrs
Interpret Vaccination result <10
No response to vaccine
Repeat course of vaccine
Recheck antibody dose after